These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12064189)

  • 21. [Ximelagatran, an oral thrombin inhibitor without the need for regular monitoring of the anticoagulant status].
    Tieleman RG
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2046-8. PubMed ID: 14606349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Update on current care guidelines. Deep thrombosis and pulmonary embolism].
    Lassila R; Halinen M; Harjola VP; Kaaja R; Kunnamo I; Manninen H; Melin J; Mustonen P; Pohjola-Sintonen S; Puurunen M; Sinisalo J; Teittinen J
    Duodecim; 2005; 121(9):1001-2. PubMed ID: 15991745
    [No Abstract]   [Full Text] [Related]  

  • 24. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient management of anticoagulation therapy.
    du Breuil AL; Umland EM
    Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative management of oral anticoagulation.
    O'Donnell M; Kearon C
    Clin Geriatr Med; 2006 Feb; 22(1):199-213, xi. PubMed ID: 16377475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current role of anticoagulants in cardiovascular medicine.
    De Caterina R
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):595-604. PubMed ID: 19571765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food].
    Sawicka-Powierza J; Rogowska-Szadkowska D; Ołtarzewska AM; Chlabicz S
    Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG; Albers GW
    J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits.
    Olshansky B; Guo H
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):571-90. PubMed ID: 16076269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of anticoagulant therapy for thromboembolism.
    Med Lett Drugs Ther; 1971 Aug; 13(17):70-1. PubMed ID: 5164090
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population.
    Nilsson GH; Björholt I; Johnsson H
    BMC Fam Pract; 2003 Apr; 4():3. PubMed ID: 12675952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term therapy of pulmonary embolism.
    Agnelli G; Becattini C
    Ital Heart J; 2005 Oct; 6(10):824-9. PubMed ID: 16270474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.
    Wittkowsky AK
    Am J Manag Care; 2004 Oct; 10(10 Suppl):S297-306; discussion S312-7. PubMed ID: 15605700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
    Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
    Scardi S; Giansante C
    Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticoagulant treatment of thrombo-embolic venous disease].
    Pinède L; Ninet J
    Rev Prat; 2003 Jan; 53(1):42-50. PubMed ID: 12673924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.